349 related articles for article (PubMed ID: 37841735)
1. Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices.
McGrath J; O'Doherty L; Conlon N; Dunne J; Brady G; Ibrahim A; McCormack W; Walsh C; Domegan L; Walsh S; Kenny C; Allen N; Fleming C; Bergin C
Front Public Health; 2023; 11():1245464. PubMed ID: 37841735
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations.
McGrath J; Kenny C; Nielsen CS; Domegan L; Walsh C; Rooney P; Walsh S; Conlon N; Brady G; Ibrahim A; Dunne J; McCormack W; Corcoran N; Allen N; Fleming C; Bergin C
Front Med (Lausanne); 2023; 10():1078022. PubMed ID: 36778745
[TBL] [Abstract][Full Text] [Related]
3. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
[TBL] [Abstract][Full Text] [Related]
4. Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples.
Kivrane A; Igumnova V; Liepina EE; Skrastina D; Leonciks A; Rudevica Z; Kistkins S; Reinis A; Zilde A; Kazaks A; Ranka R
Ups J Med Sci; 2022; 127():. PubMed ID: 35284045
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.
Sulaeman H; Grebe E; Dave H; McCann L; Di Germanio C; Sanghavi A; Sclar V; Bougie DW; Chatelain G; Biggerstaff BJ; Jones JM; Thornburg NJ; Kleinman S; Stone M; Busch MP
Microbiol Spectr; 2023 Aug; 11(4):e0323422. PubMed ID: 37347180
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
Front Immunol; 2021; 12():748291. PubMed ID: 34867975
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
8. Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody.
Duan X; Shi Y; Zhang X; Ge X; Fan R; Guo J; Li Y; Li G; Ding Y; Osman RA; Jiang W; Sun J; Luan X; Zhang G
Biosens Bioelectron; 2022 Mar; 199():113883. PubMed ID: 34942543
[TBL] [Abstract][Full Text] [Related]
9. Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay.
Resman Rus K; Korva M; Knap N; Avšič Županc T; Poljak M
J Clin Virol; 2021 Jun; 139():104820. PubMed ID: 33865031
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
Hayer J; Urlaub E
Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
[TBL] [Abstract][Full Text] [Related]
13. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.
Sil BK; Jamiruddin MR; Haq MA; Khondoker MU; Jahan N; Khandker SS; Ali T; Oishee MJ; Kaitsuka T; Mie M; Tomizawa K; Kobatake E; Haque M; Adnan N
Int J Nanomedicine; 2021; 16():4739-4753. PubMed ID: 34267520
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population.
Wehrhahn MC; Brown SJ; Newcombe JP; Chong S; Evans J; Figtree M; Hainke L; Hueston L; Khan S; Marland E; O'Sullivan MVN; Powell H; Roy J; Waring L; Yu M; Robson J
J Clin Virol; 2021 May; 138():104797. PubMed ID: 33770657
[TBL] [Abstract][Full Text] [Related]
15. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
[TBL] [Abstract][Full Text] [Related]
16. Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer.
Connelly GG; Kirkland OO; Bohannon S; Lim DC; Wilson RM; Richards EJ; Tay DM; Jee H; Hellinger RD; Hoang NK; Hao L; Chhabra A; Martin-Alonso C; Tan EKW; Koehler AN; Yaffe MB; London WB; Lee PY; Krammer F; Bohannon RC; Bhatia SN; Sikes HD; Li H
Cell Rep Methods; 2022 Aug; 2(8):100273. PubMed ID: 35942328
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2.
Olbrich L; Castelletti N; Schälte Y; Garí M; Pütz P; Bakuli A; Pritsch M; Kroidl I; Saathoff E; Guggenbuehl Noller JM; Fingerle V; Le Gleut R; Gilberg L; Brand I; Falk P; Markgraf A; Deák F; Riess F; Diefenbach M; Eser T; Weinauer F; Martin S; Quenzel EM; Becker M; Durner J; Girl P; Müller K; Radon K; Fuchs C; Wölfel R; Hasenauer J; Hoelscher M; Wieser A; On Behalf Of The KoCo-Study Group
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34623233
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
Pickering S; Betancor G; Galão RP; Merrick B; Signell AW; Wilson HD; Kia Ik MT; Seow J; Graham C; Acors S; Kouphou N; Steel KJA; Hemmings O; Patel A; Nebbia G; Douthwaite S; O'Connell L; Luptak J; McCoy LE; Brouwer P; van Gils MJ; Sanders RW; Martinez Nunez R; Bisnauthsing K; O'Hara G; MacMahon E; Batra R; Malim MH; Neil SJD; Doores KJ; Edgeworth JD
PLoS Pathog; 2020 Sep; 16(9):e1008817. PubMed ID: 32970782
[TBL] [Abstract][Full Text] [Related]
19. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
Garritsen A; Scholzen A; van den Nieuwenhof DWA; Smits APF; Datema ES; van Galen LS; Kouwijzer MLCE
Infect Dis (Lond); 2021 Jul; 53(7):498-512. PubMed ID: 33684020
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021.
Mögling R; Reimerink J; Stanoeva KR; Keramarou M; Guiomar R; Costa I; Haveri A; Holzer B; Korukluoğlu G; Nguyen T; Pakarna G; Pancer K; Trilar KP; Protic J; Stojanović M; De Santis R; Lista F; Vremera T; Leustean M; Pistol A; Zelena H; Reusken C; Broberg EK
J Virol Methods; 2023 Dec; 322():114825. PubMed ID: 37778539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
